🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Recruitingn/aAges 12 Years - anyAllTakeda
NCT07445087 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care. The treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: 1. Participants aged 12 years or older at time of initiation of Takhzyro. 2. Participants who are treated or will be treated with Takhzyro according to the approved label of South Korea. 3. The participant or legally authorized representative agrees to participate. Exclusion criteria: 1. Any of the contraindications included in the Prescribing Information (PI) for TAKHZYRO apply. 2. Participant is currently enrolled in an interventional trial.
💊

What it tests

  • No intervention
📍

Where

3 sites
Ajou University Hospital
Suwon, South Korea
Seoul National University Hospital
Seoul, South Korea
Ewha Womans University Hospital
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy